Ranbaxy, AstraZeneca Battle Looms Over Ulcer Drug
Ranbaxy filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for esomeprazole magnesium delayed-release capsules, the generic name for the widely prescribed ulcer drug Nexium. The company applied for permission to manufacture the drug in 20mg and 40mg increments.
In a letter informing AstraZeneca of its decision to...
To view the full article, register now.